May 18, 2018 / 6:02 PM / 5 months ago

BRIEF-GTx Updates Phase 2 Enobosarm Clinical Trial Results

May 18 (Reuters) - GTX Inc:

* GTX UPDATES PHASE 2 ENOBOSARM CLINICAL TRIAL RESULTS IN STRESS URINARY INCONTINENCE AT 2018 AUA ANNUAL MEETING

* GTX INC - TOP-LINE RESULTS FROM ASTRID, AN ONGOING PHASE 2 PLACEBO-CONTROLLED CLINICAL TRIAL, ARE EXPECTED EARLY IN Q4 OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below